Literature DB >> 6328660

Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.

D Klatzmann, F Barré-Sinoussi, M T Nugeyre, C Danquet, E Vilmer, C Griscelli, F Brun-Veziret, C Rouzioux, J C Gluckman, J C Chermann.   

Abstract

Lymphadenopathy associated virus ( LAV ) has been isolated from patients with the acquired immunodeficiency syndrome (AIDS) or lymphadenopathy syndrome. Since the immune deficiency in AIDS seems to be primarily related to the defect of the helper-inducer T lymphocyte subset, the possibility that LAV is selectively tropic for this subset was investigated. Fractionation of T lymphocytes was achieved by cellular affinity chromatography with monoclonal antibodies. In a hemophilic patient who was a healthy carrier of LAV , reverse transcriptase activity and virus particles detected by electron microscopy were found only in cultures of helper-inducer lymphocytes. When infected with LAV in vitro, lymphocyte subsets from normal individuals yielded similar results. Virus production was associated with impaired proliferation, modulation of T3-T4 cell markers, and the appearance of cytopathic effects. The results provide evidence for the involvement of LAV in AIDS.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328660     DOI: 10.1126/science.6328660

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  234 in total

1.  Expression of CD4 by human megakaryocytes.

Authors:  R S Basch; Y H Kouri; S Karpatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody.

Authors:  W A Marasco; J Bagley; C Zani; M Posner; L Cavacini; W A Haseltine; J Sodroski
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

3.  Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors.

Authors:  Cleve O James; Ming-Bo Huang; Mafuz Khan; Minerva Garcia-Barrio; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

4.  Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding.

Authors:  U Olshevsky; E Helseth; C Furman; J Li; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

5.  Immunohistology of tuberculous adenitis in symptomatic HIV infection.

Authors:  J Y Shen; P F Barnes; T H Rea; P R Meyer
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

6.  Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1.

Authors:  D C Montefiori; W E Robinson; W M Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Formation of IgE-binding factors by T cells of patients infected with human immunodeficiency virus type 1.

Authors:  C Carini; J Margolick; J Yodoi; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study.

Authors:  J M Orenstein; M S Meltzer; T Phipps; H E Gendelman
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  Functional epitope analysis of the human CD4 molecule: antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4.

Authors:  M Benkirane; M Hirn; D Carrière; C Devaux
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  In vivo lymphocyte tropism of feline immunodeficiency virus.

Authors:  R V English; C M Johnson; D H Gebhard; M B Tompkins
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.